Arpeggio Biosciences
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $23M
Investors
- 10
About Arpeggio Biosciences
Founded in 2017 in Boulder, US, Arpeggio Biosciences, Inc. delivers innovative solutions in transcriptomic sequencing.Arpeggio Biosciences, Inc.3 billion mRNAs.The company generates revenue through partnerships with pharmaceutical and biotech firms, providing access to their sequencing platform and associated services. The company plans to further develop its product offerings and expand into new global markets, leveraging recent investments to accelerate growth initiatives.
Who invested in Arpeggio Biosciences
10 investors across 2 rounds
See all investors in Arpeggio Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arpeggio Biosciences
Who invested in Arpeggio Biosciences?
Arpeggio Biosciences has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arpeggio Biosciences raised?
Arpeggio Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arpeggio Biosciences last raise money?
Arpeggio Biosciences's most recent round on record is a Series A, in Aug 2022.
What does Arpeggio Biosciences do?
Founded in 2017 in Boulder, US, Arpeggio Biosciences, Inc.
Where is Arpeggio Biosciences headquartered?
Arpeggio Biosciences is headquartered in Boulder, US.
Which VCs invest in companies like Arpeggio Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arpeggio Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Arpeggio Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.